FT商学院

Superdrug owner shrugs off volatility to press ahead with $30bn dual listing
屈臣氏无惧市场波动,推进300亿美元双重上市计划

AS Watson plans to publicly trade shares in both Hong Kong and London before the end of 2026
屈臣氏集团计划在2026年底前将其股票分别在香港和伦敦公开上市交易。